The antiallergic drug disodium cromoglycate (DSCG) selectively inhibits allogeneic responses in mixed lymphocyte culture (MLC) reactions, but does not affect cell viability or suppress lymphocyte responses to mitogens. Preincubation experiments with DSCG were without effect, indicating that the drug does not bind to unstimulated lymphocytes. Timed studies demonstrated maximal MLC inhibition when DSCG was added during the first 12 h of culture and no effect if added later than 72 h. Both natural killing and cell-mediated lympholysis (CML) assays proceeded normally in the presence of optimal MLC-inhibitory concentrations of DSCG. CML reactions were eliminated, however, by the presence of drug during generation of cytotoxic T cells. The proposed mode of action for DSCG is blocking of calcium influx across cell membranes, thereby inhibiting the release of mast cell and basophil granules in hypersensitivity reactions. Such a mechanism would seem unlikely for DSCG-mediated lymphocyte effects as several calcium-dependent lymphocyte functions are not obstructed.

This content is only available via PDF.
© 1981 S. Karger AG, Basel
1981
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.